Transgenomic to Present at the Craig-Hallum 4th Annual Alpha Select Conference
September 24 2013 - 10:05AM
Business Wire
Transgenomic, Inc. (OTCBB: TBIO) today announced that
Craig Tuttle, Chief Executive Officer of Transgenomic, will be
presenting at the Craig-Hallum Capital Group’s 2013 Alpha Select
Investor Conference on Thursday, September 26th at 1:25 PM Eastern
Time at Convene in New York City.
About Transgenomic
Transgenomic, Inc. (www.transgenomic.com) is a global
biotechnology company advancing personalized medicine in
cardiology, oncology, and inherited diseases through its
proprietary molecular technologies and world-class clinical and
research services. The Company is a global leader in cardiac
genetic testing with a family of innovative products, including its
C-GAAP test, designed to detect gene mutations which indicate
cardiac disorders, or which can lead to serious adverse events.
Transgenomic has three complementary business divisions:
Transgenomic Clinical Laboratories, which specializes in molecular
diagnostics for cardiology, oncology, neurology, and mitochondrial
disorders; Transgenomic Pharmacogenomic Services, a contract
research laboratory that specializes in supporting all phases of
pre-clinical and clinical trials for oncology drugs in development;
and Transgenomic Diagnostic Tools, which produces equipment,
reagents, and other consumables that empower clinical and research
applications in molecular testing and cytogenetics. Transgenomic
believes there is significant opportunity for continued growth
across all three businesses by leveraging their synergistic
capabilities, technologies, and expertise. The Company actively
develops and acquires new technology and other intellectual
property that strengthens its leadership in personalized
medicine.
Investor ContactArgot PartnersDavid Pitts,
212-600-1902david@argotpartners.comorCompany
ContactTransgenomic, Inc.Investor Relations,
402-452-5416investorrelations@transgenomic.com
Telesis Bio (PK) (USOTC:TBIO)
Historical Stock Chart
From Nov 2024 to Dec 2024
Telesis Bio (PK) (USOTC:TBIO)
Historical Stock Chart
From Dec 2023 to Dec 2024
